176 related articles for article (PubMed ID: 25013321)
1. Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?
Tripathi P; Agrawal H; Goyal P; Kar SK
Ind Psychiatry J; 2013 Jul; 22(2):159-60. PubMed ID: 25013321
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of voluntary reporting of adverse drug events related to antipsychotics in Australia: 14-year analysis.
Khalil H; Hoppe D; Ameen N
Ther Adv Drug Saf; 2021; 12():20420986211012854. PubMed ID: 34104400
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Croarkin PE; Emslie GJ; Mayes TL
J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report.
Szota AM; Radajewska I; Grudzka P; Araszkiewicz A
BMC Psychiatry; 2020 Apr; 20(1):179. PubMed ID: 32306929
[TBL] [Abstract][Full Text] [Related]
6. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
7. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
8. Ziprasidone versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; Bhoopathi PS; Kissling W; Leucht S
Cochrane Database Syst Rev; 2009 Oct; (4):CD006627. PubMed ID: 19821380
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.
Trollor JN; Chen X; Sachdev PS
CNS Drugs; 2009; 23(6):477-92. PubMed ID: 19480467
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome in a patient treated with lithium carbonate and haloperidol.
Yang Y; Guo Y; Zhang A
Shanghai Arch Psychiatry; 2014 Dec; 26(6):368-70. PubMed ID: 25642114
[TBL] [Abstract][Full Text] [Related]
13. Medical care costs and hospitalization in patients with bipolar disorder treated with atypical antipsychotics.
Bergeson JG; Kalsekar I; Jing Y; You M; Forbes RA; Hebden T
Am Health Drug Benefits; 2012 Sep; 5(6):379-86. PubMed ID: 24991334
[TBL] [Abstract][Full Text] [Related]
14. [Antipsychotic Treatment of the Adult Patient in the Acute Phase of Schizophrenia].
Bohórquez Peñaranda A; Gómez Restrepo C; García Valencia J; Jaramillo González LE; de la Hoz AM; Arenas Á; Tamayo Martínez N
Rev Colomb Psiquiatr; 2014; 44 Suppl 1():13-28. PubMed ID: 26576459
[TBL] [Abstract][Full Text] [Related]
15. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
16. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.
Zhu B; Kulkarni PM; Stensland MD; Ascher-Svanum H
Curr Med Res Opin; 2007 Nov; 23(11):2805-14. PubMed ID: 17910804
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Schmid F; Hunger H; Schwarz S; Srisurapanont M; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Jan; (1):CD006625. PubMed ID: 20091600
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine induced neuroleptic malignant syndrome.
Patra BN; Khandelwal SK; Sood M
Indian J Pharmacol; 2013; 45(1):98-9. PubMed ID: 23543750
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
[TBL] [Abstract][Full Text] [Related]
20. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
